In these roles, Sarin and Conly will be responsible for driving global strategic, operational and commercial performance of their respective business units. Sarin will report to
'Puneet has proven strategic and operational performance as a business unit president at BD and is well positioned to lead MMS into the future,' Garrison said. 'Puneet has reinvigorated our Biosciences business through several new innovations and customer experience improvements that have solidified BD's leadership in flow cytometry and immunology. I look forward to transitioning the MMS president role to Puneet as we continue to focus on the fundamentals, further our commitment culture and drive innovation for advancing health care worldwide.
Hickey added, 'Steve is a known expert and leader in the life sciences industry and has spent 12 years at BD leading multiple platforms across both Integrated Diagnostic Solutions and Biosciences, most recently as the P&L leader for all of our research and clinical solutions platforms across BDB. Promoting Steve to president at BDB was part of our robust, planned succession process, and I am fully confident that he will continue to drive innovation and growth at BDB.'
Sarin, 48, replaces
Conly, 39, replaces Sarin who has been named president of MMS. Conly joined BD in 2010 as a marketing manager for Laboratory Automation in the Integrated Diagnostic Solutions business. He was promoted to platform leader for Laboratory Automation in 2012 and was then appointed to the platform leadership position for Microbiology in 2015. Conly was promoted to VP and
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Contact:
Tel: 858.617.2361
Email: troy.kirkpatrick@bd.com
(C) 2022 Electronic News Publishing, source